Design, construction and expression of chimeric proteins for development of vaccines and diagnostic reagents
CA 2084136 A1 · Owner: Korea Green Cross Corporation · Inventors: Luo, Lizhong; Kang, Chil-Yong
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The chimeric proteins, and the vaccine compring the chimeric protein are disclosed. The preparation comprises linking gag of HIV to env to form the chimeric gene, inserting the obtained chimeric gene into the DNA of baculovirus, infecting the resulted recommbinant virus with the insect cells or insect, culturing it and purifying the obtained chimeric protein. The gag chimeric protein of HIV according to the present invention retains both antigenic and immunogenic properties.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 21, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 21, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 21, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.